Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Century Therapeutics Inc (IPSC)

Century Therapeutics Inc (IPSC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,347,043
  • Shares Outstanding, K 54,404
  • Annual Sales, $ 0 K
  • Annual Income, $ -53,575 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade IPSC with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.93
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.40
  • Number of Estimates 4
  • High Estimate -0.36
  • Low Estimate -0.43
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.03 +7.51%
on 08/27/21
32.22 -23.15%
on 08/19/21
-5.30 (-17.63%)
since 08/17/21

Most Recent Stories

More News
Hercules Capital Reports Second Quarter 2021 Financial Results

--Record Year-to-Date Total Fundings of $634.0 Million

BASE : 34.74 (-4.01%)
UP : 7.48 (-4.23%)
ASPL : 9.93 (+0.30%)
RPID : 20.13 (-4.78%)
IPSC : 24.76 (-15.35%)
CXM : 18.01 (-4.86%)
ZETA : 6.31 (-8.15%)
XMTR : 62.47 (-6.84%)
PTRA : 10.32 (+0.68%)
ACTC : 18.09 (-4.84%)
ME : 8.34 (+3.09%)
PRVA : 27.06 (+0.26%)
CPSR : 9.95 (unch)
KVSB : 10.28 (+2.09%)
DMYQ : 9.99 (unch)
VACQ : 11.57 (+4.52%)
SPFR : 9.98 (-0.30%)
JCS : 8.30 (+4.01%)
PACE : 11.16 (+10.93%)
HTGC : 16.78 (-0.36%)
HCXY : 26.94 (+0.52%)
Century Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced the closing of its initial...

JPM : 157.68 (-0.26%)
IPSC : 24.76 (-15.35%)

Business Summary

Century Therapeutics Inc. is a cell therapy company. It involved in developing induced pluripotent stem cell -derived cell therapies in immuno-oncology. Century Therapeutics Inc. is based in PHILADELPHIA.

See More

Key Turning Points

3rd Resistance Point 34.36
2nd Resistance Point 32.34
1st Resistance Point 28.55
Last Price 24.76
1st Support Level 22.74
2nd Support Level 20.72
3rd Support Level 16.93

See More

52-Week High 32.90
Fibonacci 61.8% 27.56
Fibonacci 50% 25.91
Last Price 24.76
Fibonacci 38.2% 24.26
52-Week Low 18.92

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar